 |
Alder Biopharmaceuticals - uniquely identifies, develops, and manufactures novel antibody therapeutics to alleviate human suffering in the autoimmune and inflammatory disease areas. |
 |
Aquinox Pharmaceuticals - a privately-held pharmaceutical company developing targeted small molecule therapeutics for the treatment of cancer and inflammatory disease. |
 |
Celator Pharmaceuticals - a private North American biopharmaceutical company developing new technology for targeting combinations of rationally selected chemotherapeutic agents to sites of disease. |
 |
MacroGenics - MacroGenics is developing immune-based products including monoclonal antibodies to treat patients with cancer, autoimmune disorders, allergy, or infectious diseases and vaccines to prevent infections in healthy individuals. |
 |
NeurAxon - NeurAxon is an early stage research and discovery company dedicated to addressing the growing unmet medical need in the area of pain management. |
 |
Novadaq Technologies - develops and commercializes medical devices based on its proprietary imaging platform for the diagnosis and treatment of human vascular and ophthalmic diseases and conditions. (TSX: NDQ) |
 |
Presidio Pharmaceuticals - specialty pharmaceutical company focused on developing and commercializing novel, small molecule compounds for the treatment of HIV-1, HCV and other chronic viral infections. |
 |
Xenon Pharmaceuticals - drug discovery using clinical genetics and functional genomics. |
